Condition

VTE (Venous Thromboembolism) clinical trials and research

• 6Clinical trials
• 5Countries

Newest VTE (Venous Thromboembolism) clinical trials

All recruiting trials (6)

• Rivaroxaban vs Enoxaparin After Cesarean Section: Thromboprophylaxis Lab Outcomes

  This study tests whether rivaroxaban taken by mouth once daily after cesarean section provides a similar lab profile for blood clot prevention as enoxaparin given as a daily shot in eligible postpartum women.

  Recruiting Wolfson Medical Center · Holon · NCT07820670

• Reduced‑dose apixaban or rivaroxaban versus daily low‑molecular‑weight heparin for people with blood cancers

  This trial will test whether reduced‑dose apixaban or rivaroxaban pills can prevent blood clots as well and as safely as daily low‑molecular‑weight heparin injections in people with hematologic malignancies.

  Recruiting Medical University of Gdansk · Gdansk, Pomeranian Voivodeship · NCT07270263

• Apixaban dosing options to prevent blood clots in people with cancer

  This study will test whether taking apixaban once a day, twice a day, or not taking anticoagulants helps prevent blood clots and death in adults with solid tumors or lymphoma who have a Khorana score of 2.

  Recruiting Phase 3 University of Vermont · Burlington, Vermont · NCT07005024

• Rivaroxaban in breast milk after maternal dosing

  This will test how much rivaroxaban passes into breast milk in postpartum people taking either prophylactic (10 mg) or therapeutic (20 mg) doses.

  Recruiting Phase 1 Thomas Jefferson University · Philadelphia, Pennsylvania · NCT06831474

• Evaluating the AQT90 FLEX D-dimer Test for diagnosing Venous Thromboembolism

  This study is testing the AQT90 FLEX D-dimer Test to see if it can help diagnose Venous Thromboembolism in patients who might have a low or moderate chance of having the condition.

  Recruiting Radiometer Medical ApS · Viborg · NCT06749223

• Padua Score to predict VTE risk in thoracic surgery patients

  This study tests whether the Padua Prediction Score can better predict VTE risk in people undergoing thoracic surgery.

  Recruiting Al-Nahrain University · Baghdad, Kadhimiya · NCT06732726

Related topics

Quick answers

How many VTE (Venous Thromboembolism) clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (2 trials), Denmark (1 trial), Israel (1 trial), Poland (1 trial), Iraq (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →